You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 287 No. 7, February 20, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (40)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Bacterial Infections
 •Bioterrorism
 •Diagnosis
 •Alert me on articles by topic

Bioterrorism Preparedness and Response

Clinicians and Public Health Agencies as Essential Partners

Julie Louise Gerberding, MD,MPH; James M. Hughes, MD; Jeffrey P. Koplan, MD,MPH

JAMA. 2002;287:898-900.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Beginning in mid-September 2001, the United States experienced unprecedented biological attacks involving the intentional distribution of Bacillus anthracis spores through the postal system.1 The full impact of this bioterrorist activity has not been assessed, but already the toll is large. A total of 22 persons have developed anthrax and 5 have died as a direct result.2-5 More than 10 000 persons were advised to take postexposure prophylactic treatment because they were at known or potential risk for inhalational anthrax; in addition, more than 20 000 others started such treatment until the investigation provided reassurance that exposure was unlikely and treatment could be stopped; thousands more were victims of hoaxes or false alarms, and still more were worried coworkers, friends, and family members of those directly affected.6 The impact was not limited to the United States. Hoaxes involving threatening letters or . . . [Full Text of this Article]

Author Affiliations: Centers for Disease Control and Prevention, Atlanta, Ga.


RELATED ARTICLES

Fatal Inhalational Anthrax With Unknown Source of Exposure in a 61-Year-Old Woman in New York City
Bushra Mina, J. P. Dym, Frank Kuepper, Raymond Tso, Carmina Arrastia, Irina Kaplounova, Hasan Faraj, Agnieszka Kwapniewski, Christopher M. Krol, Mayer Grosser, Jeffrey Glick, Steven Fochios, Athena Remolina, Ljiljana Vasovic, Jeffrey Moses, Thomas Robin, Maria DeVita, and Michael L. Tapper
JAMA. 2002;287(7):858-862.
ABSTRACT | FULL TEXT  

Fatal Inhalational Anthrax in a 94-Year-Old Connecticut Woman
Lydia A. Barakat, Howard L. Quentzel, John A. Jernigan, David L. Kirschke, Kevin Griffith, Stephen M. Spear, Katherine Kelley, Diane Barden, Donald Mayo, David S. Stephens, Tanja Popovic, Chung Marston, Sherif R. Zaki, Jeanette Guarner, Wun-Ju Shieh, H. Wayne Carver II, Richard F. Meyer, David L. Swerdlow, Eric E. Mast, James L. Hadler, and for the Anthrax Bioterrorism Investigation Team
JAMA. 2002;287(7):863-868.
ABSTRACT | FULL TEXT  

Cutaneous Anthrax Associated With Microangiopathic Hemolytic Anemia and Coagulopathy in a 7-Month-Old Infant
Abigail Freedman, Olubunmi Afonja, Mary Wu Chang, Farzad Mostashari, Martin Blaser, Guillermo Perez-Perez, Herb Lazarus, Robert Schacht, Jane Guttenberg, Michael Traister, and William Borkowsky
JAMA. 2002;287(7):869-874.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

ACCF/AHA/CDC Conference Report on Emerging Infectious Diseases and Biological Terrorism Threats: The Clinical and Public Health Implications for the Prevention and Control of Cardiovascular Diseases
Mensah et al.
J Am Coll Cardiol 2007;49:1376-1379.
FULL TEXT  

ACCF/AHA/CDC Conference Report on Emerging Infectious Diseases and Biological Terrorism Threats: The Clinical and Public Health Implications for the Prevention and Control of Cardiovascular Diseases
Mensah et al.
J Am Coll Cardiol 2007;0:j.jacc.2007.01.008v2-12733.
FULL TEXT  

Discriminating Inhalational Anthrax From Community-Acquired Pneumonia Using Chest Radiograph Findings and a Clinical Algorithm
Kyriacou et al.
Chest 2007;131:489-496.
ABSTRACT | FULL TEXT  

A National Survey of Terrorism Preparedness Training Among Pediatric, Family Practice, and Emergency Medicine Programs
Martin et al.
Pediatrics 2006;118:e620-e626.
ABSTRACT | FULL TEXT  

Hawaii Veterinarians' Bioterrorism Preparedness Needs Assessment Survey
Katz et al.
jvme 2006;33:612-617.
ABSTRACT | FULL TEXT  

Antibiotics for Anthrax: Patient Requests and Physician Prescribing Practices During the 2001 New York City Attacks
Hupert et al.
Arch Intern Med 2004;164:2012-2016.
ABSTRACT | FULL TEXT  

Accuracy of Screening for Inhalational Anthrax after a Bioterrorist Attack
Hupert et al.
ANN INTERN MED 2003;139:337-345.
ABSTRACT | FULL TEXT  

Bioterrorism and catastrophe response: A quick-reference guide to resources
HAN et al.
Journal of the American Dental Association 2003;134:745-752.
ABSTRACT | FULL TEXT  

National Inventory of Hospital Trauma Centers
MacKenzie et al.
JAMA 2003;289:1515-1522.
ABSTRACT | FULL TEXT  

Guest Editorial: Terrorism and Aging
Salerno and Nagy
J. Gerontol. A Biol. Sci. Med. Sci. 2002;57:M552-554.
FULL TEXT  

Early statistical detection of anthrax outbreaks by tracking over-the-counter medication sales
Goldenberg et al.
Proc. Natl. Acad. Sci. USA 2002;99:5237-5240.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.